Abstract
Background EuroSCORE has been proposed to identify patients at high risk for surgical aortic valve replacement and estimate for them the risk-benefit of percutaneous implantation. However, it has been clearly demonstrated that this system overestimates mortality, particularly in the elderly population undergoing surgery for aortic valve replacement. An actualized model called EuroSCORE II has been recently proposed to predict mortality after cardiac surgery but it has not been validated yet in the elderly population undergoing aortic valve replacement. We aimed to validate the new risk model in an octogenarian population who underwent surgery for aortic valve replacement in our center. Methods
Highlights
EuroSCORE has been proposed to identify patients at high risk for surgical aortic valve replacement and estimate for them the risk-benefit of percutaneous implantation
It has been clearly demonstrated that this system overestimates mortality, in the elderly population undergoing surgery for aortic valve replacement
EuroSCORE II is a good model for predicting mortality after surgery for aortic valve replacement in octogenarians
Summary
EuroSCORE has been proposed to identify patients at high risk for surgical aortic valve replacement and estimate for them the risk-benefit of percutaneous implantation. It has been clearly demonstrated that this system overestimates mortality, in the elderly population undergoing surgery for aortic valve replacement. An actualized model called EuroSCORE II has been recently proposed to predict mortality after cardiac surgery but it has not been validated yet in the elderly population undergoing aortic valve replacement. We aimed to validate the new risk model in an octogenarian population who underwent surgery for aortic valve replacement in our center. Observed in the first three quartiles but not in the fourth (Hosmer-Lemeshow, p=0,032; risk adjusted mortality ratio=1,93). Similar results were obtained in the subgroup of patients who underwent isolated replacement
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
